Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurosurgery

Surgery, Radiation, and the Path to Control

At a Glance

Meningioma treatment typically involves surgery, radiation, or both. Surgeons prioritize preserving brain function over complete removal. When tumors involve vital structures, leaving a small piece behind and treating it with targeted radiation is often the safest path to long-term control.

When a meningioma becomes symptomatic or shows significant growth, the conversation shifts toward active treatment. The standard of care generally involves surgery, radiation, or a combination of both [1]. The goal is to provide long-term control of the tumor while protecting your quality of life.

Surgery and the Simpson Scale

The primary goal of surgery is to remove as much of the tumor as safely possible. For decades, neurosurgeons have used the Simpson Scale to describe how “complete” a resection was. This scale helps predict whether a tumor will come back [1][2].

Simpson Grade Definition Impact on Recurrence
Grade 1 Total removal of the tumor, its attachment to the membrane (dura), and any affected bone. Lowest risk of recurrence [1].
Grade 2 Total removal of the tumor, but the attachment point is treated with heat (cauterized) rather than removed. Low risk of recurrence [2].
Grade 3 Total removal of the tumor, but the attachment point is left untreated. Moderate risk of recurrence [3].
Grade 4 Subtotal removal (some tumor is intentionally left behind to protect vital structures). Managed risk of recurrence. While regrowth is more likely, it is usually very slow and controlled with targeted radiation [4].
Grade 5 Simple decompression or biopsy (taking a small sample). Highest risk [3].

A Note on Grade 4: While a Simpson Grade 1 is the theoretical “gold standard,” modern surgeons prioritize your safety over total completeness. If a tumor is wrapped around a critical blood vessel or nerve, intentionally leaving a small piece behind (Grade 4) and treating it with radiation is often the safest, most successful strategy to preserve your quality of life [1].

What to Expect: Surgery and Recovery

The idea of brain surgery is terrifying, and knowing what actually happens can help reduce anxiety.

  • Preparation: You will likely need imaging and pre-operative blood work. Surgeons today rarely shave your entire head; usually, they only shave a small, minimal strip over the specific incision site.
  • The Hospital Stay: After surgery, you will typically spend 1 to 2 days in the Intensive Care Unit (ICU) so the team can closely monitor your neurological function. Afterward, you will move to a regular hospital room. The total stay usually ranges from 3 to 7 days, depending on your progress.
  • Physical Recovery: You will likely feel immense fatigue and may have headaches. Full recovery takes time—often 4 to 8 weeks before returning to normal activities, though this varies widely depending on the tumor’s location and your overall health.

Radiation Therapy: Targeted Control

Radiation may be used as the primary treatment for small, hard-to-reach tumors, or as an “add-on” (adjuvant therapy) after a subtotal resection (like a Simpson Grade 4) [1][5].

  • Stereotactic Radiosurgery (SRS): This is not “surgery” with a knife, but a highly focused beam of high-dose radiation delivered in a single session. It is typically used for smaller WHO Grade 1 tumors [6].
  • Fractionated Radiotherapy: This involves smaller doses of radiation delivered over several weeks. It is often preferred for larger tumors or those located near sensitive structures like the optic nerves, as it is gentler on healthy tissue [7][8].
  • Adjuvant Radiation: For WHO Grade 2 and 3 tumors, radiation is frequently recommended after surgery to kill any remaining cells, regardless of how much was removed [1][9].

Evaluating Surgical Risk: Age vs. Frailty

A common misconception is that “old age” makes surgery too dangerous. However, research shows that frailty—a measure of your body’s overall reserve and health—is a much better predictor of how you will recover than your birth year [10][11].

Doctors use tools like the modified Frailty Index (mFI) to look at factors like your history of heart disease, diabetes, and functional independence [12]. A person in their 80s who is physically active and has few health issues may actually be a better surgical candidate than a younger person with significant “frailty” [13].

Return to Home | Previous: Decoding Your Pathology Report | Next: High-Grade and Recurrent Therapies

Common questions in this guide

What is the Simpson Scale for meningioma surgery?
The Simpson Scale is a grading system neurosurgeons use to describe how completely a meningioma and its attachments were removed. A Grade 1 indicates total removal, while a Grade 4 means some of the tumor was intentionally left behind to protect vital brain structures.
Is it safe to leave part of the meningioma behind during surgery?
Yes, modern neurosurgeons prioritize your safety and quality of life over completely removing the tumor. If a meningioma is wrapped around critical nerves or blood vessels, intentionally leaving a small piece behind and treating it with radiation is often the safest strategy.
What should I expect during recovery from brain surgery?
Following surgery, you will typically spend one to two days in the intensive care unit for close monitoring, then move to a regular hospital room for a few days. Complete physical recovery often takes four to eight weeks, during which you may experience significant fatigue and headaches.
Am I too old for meningioma brain surgery?
Chronological age alone does not determine if surgery is safe for you. Doctors look at your overall 'frailty,' which accounts for your functional independence and conditions like heart disease or diabetes. An active older adult may actually be a safer surgical candidate than a younger person with significant health problems.
How is radiation therapy used to treat meningiomas?
Radiation can be used as the main treatment for small, hard-to-reach tumors, or applied after surgery to target any remaining tumor cells. It may be delivered in a single, highly focused session called stereotactic radiosurgery, or in smaller daily doses over several weeks to protect healthy brain tissue.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my tumor's location, what is the goal for the extent of resection—a Simpson Grade 1, or is a subtotal resection (Grade 4) safer?
  2. 2.Do you use intraoperative tools, like 5-ALA fluorescence, to help distinguish the tumor from normal brain tissue?
  3. 3.If you cannot remove the entire tumor, what is the plan for the remaining piece—radiation or observation?
  4. 4.How many meningiomas of this specific type and location do you operate on each year?
  5. 5.How does my 'frailty score' (like the modified Frailty Index) compare to my chronological age in terms of surgical risk?
  6. 6.Given the tumor's size and proximity to critical structures, would you recommend Stereotactic Radiosurgery (SRS) or Fractionated Radiotherapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Prognostic Factors and Outcomes in World Health Organization Grade 1 and Grade 2 Intracranial Meningiomas-5-Year Institutional Experience.

    Nadeem M, Goyal-Honavar A, Sravya P, et al.

    World neurosurgery 2024; (187()):e331-e339 doi:10.1016/j.wneu.2024.04.082.

    PMID: 38649022
  2. 2

    Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.

    Prat-Acín R, Guarín-Corredor MJ, Galeano-Senabre I, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021; (86()):32-37 doi:10.1016/j.jocn.2021.01.009.

    PMID: 33775343
  3. 3

    Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience.

    Przybylowski CJ, Hendricks BK, Frisoli FA, et al.

    Journal of neurosurgery 2021; (135(2)):515-523 doi:10.3171/2020.6.JNS20374.

    PMID: 33096534
  4. 4

    Management of intracranial meningioma: Outcome analysis and clinico radiological profile of 172 patients.

    Varshney A, Jaiswal S, Bajaj A, et al.

    Surgical neurology international 2024; (15()):464 doi:10.25259/SNI_556_2024.

    PMID: 39777178
  5. 5

    Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.

    Song D, Xu D, Han H, et al.

    Frontiers in oncology 2021; (11()):787962 doi:10.3389/fonc.2021.787962.

    PMID: 34926303
  6. 6

    Stereotactic Radiosurgery for Intracranial Noncavernous Sinus Benign Meningioma: International Stereotactic Radiosurgery Society Systematic Review, Meta-Analysis and Practice Guideline.

    Marchetti M, Sahgal A, De Salles AAF, et al.

    Neurosurgery 2020; (87(5)):879-890 doi:10.1093/neuros/nyaa169.

    PMID: 32463867
  7. 7

    The Recent Management of Vestibular Schwannoma Radiotherapy: A Narrative Review of the Literature.

    Brun L, Mom T, Guillemin F, et al.

    Journal of clinical medicine 2024; (13(6)) doi:10.3390/jcm13061611.

    PMID: 38541837
  8. 8

    Effects of two different radiotherapies for craniopharyngiomas using stereotactic radiosurgery/ stereotactic radiotherapy or fractionated stereotactic radiotherapy.

    Kamogawa M, Shuto T, Matsunaga S

    Surgical neurology international 2022; (13()):563 doi:10.25259/SNI_802_2022.

    PMID: 36600746
  9. 9

    Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.

    Orton A, Frandsen J, Jensen R, et al.

    Journal of neurosurgery 2018; (128(6)):1684-1689.

    PMID: 28731397
  10. 10

    Preoperative frailty and postoperative complications after non-cardiac surgery: a systematic review.

    Becerra-Bolaños Á, Hernández-Aguiar Y, Rodríguez-Pérez A

    The Journal of international medical research 2024; (52(9)):3000605241274553 doi:10.1177/03000605241274553.

    PMID: 39268763
  11. 11

    A simplified preoperative risk assessment tool as a predictor of complications in the surgical management of forearm fractures.

    Congiusta D, Amer K, Pooja Suri D, et al.

    Journal of clinical orthopaedics and trauma 2021; (14()):121-126 doi:10.1016/j.jcot.2020.07.014.

    PMID: 33680818
  12. 12

    The modified frailty index and 30-day adverse events in oncologic neurosurgery.

    Youngerman BE, Neugut AI, Yang J, et al.

    Journal of neuro-oncology 2018; (136(1)):197-206 doi:10.1007/s11060-017-2644-0.

    PMID: 29139096
  13. 13

    The 5-factor modified frailty index: an effective predictor of mortality in brain tumor patients.

    Khalafallah AM, Huq S, Jimenez AE, et al.

    Journal of neurosurgery 2021; (135(1)):78-86 doi:10.3171/2020.5.JNS20766.

    PMID: 32796147

This page is for informational purposes only and does not replace professional medical advice. Always consult your neurosurgeon or radiation oncologist about your specific tumor, treatment options, and surgical risks.

Get notified when new evidence is published on Meningioma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.